UK Markets closed

Orphazyme A/S (ORPH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.33-7.23 (-49.66%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5264.94M
Enterprise value 3-341.68M
Trailing P/E N/A
Forward P/E 1-3.66
PEG ratio (5-yr expected) 1-0.06
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 70.56

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 377.77
52-week low 34.75
50-day moving average 37.33
200-day moving average 310.35

Share statistics

Avg vol (3-month) 34.02M
Avg vol (10-day) 335.68M
Shares outstanding 534.95M
Implied shares outstanding 6N/A
Float 24.59M
% held by insiders 10.00%
% held by institutions 10.50%
Shares short (14 Apr 2021) 422.27k
Short ratio (14 Apr 2021) 40.16
Short % of float (14 Apr 2021) 4N/A
Short % of shares outstanding (14 Apr 2021) 40.06%
Shares short (prior month 14 Mar 2021) 417.8k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-75.82%
Return on equity (ttm)-188.05%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -606.45M
Net income avi to common (ttm)-633.25M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)726.93M
Total cash per share (mrq)20.8
Total debt (mrq)70.71M
Total debt/equity (mrq)11.40
Current ratio (mrq)4.70
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-539.08M
Levered free cash flow (ttm)-313.73M